Banks scramble to assemble Asian biotech IPO resources via @FT https://t.co/4PAHrqjMET — The Propell Group (@ThePropellGroup) May 9, 2018
How too much fructose may cause liver damage https://t.co/UiZEFlp30W — The Propell Group (@ThePropellGroup) May 9, 2018
Tencent’s WeDoctor closes fund-raising round, valued at $5.5 billion | Article [AMP] | Reuters https://t.co/4hZrK2RBQc
0 0
Tencent’s WeDoctor closes fund-raising round, valued at $5.5 billion | Article [AMP] | Reuters https://t.co/4hZrK2RBQc — The Propell Group (@ThePropellGroup) May 9, 2018
Google makes a nod to ‘digital wellness’ as it steams ahead in AI via @FT https://t.co/l5FTs7AatA
0 0
Google makes a nod to ‘digital wellness’ as it steams ahead in AI via @FT https://t.co/l5FTs7AatA — The Propell Group (@ThePropellGroup) May 9, 2018
India’s healthcare: does Modi have the right cure? via @FT https://t.co/0BriaIv5Oz — The Propell Group (@ThePropellGroup) May 8, 2018
Shire board recommends £46bn takeover by Takeda via @FT https://t.co/KTfLz1MTHo — The Propell Group (@ThePropellGroup) May 8, 2018
What’s the future of clinical trial design? Medidata sees a blend of virtual and in-person components https://t.co/IQ9f32AEgL
0 0
What’s the future of clinical trial design? Medidata sees a blend of virtual and in-person components https://t.co/IQ9f32AEgL — The Propell Group (@ThePropellGroup) May 8, 2018
FitBit looks for new value pools in HealthTech https://t.co/PoXraYaRNW — The Propell Group (@ThePropellGroup) May 8, 2018
HealthTech in Asia: Caveat Emptor, Caveat Venditor https://t.co/FNNSm3Rdwk — The Propell Group (@ThePropellGroup) May 8, 2018
https://t.co/8zDfaMslSv — The Propell Group (@ThePropellGroup) May 8, 2018